Eledon Pharmaceuticals Inc
F:2TK
Eledon Pharmaceuticals Inc
F:2TK
Price:
1.92
EUR
-4%
Market Closed
Market Cap:
€73.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Eledon Pharmaceuticals Inc
F:2TK
|
US |
|
enCore Energy Corp
XTSX:EU
|
CA |
|
S
|
Stryker Corp
XMUN:SYK
|
US |
|
S
|
SK Discovery Co Ltd
KRX:006120
|
KR |
|
Gap Inc
NYSE:GAP
|
US |
|
A
|
Akanda Corp
NASDAQ:AKAN
|
UK |
|
Eni SpA
NYSE:E
|
IT |
|
Chateau International Development Co Ltd
TWSE:2722
|
TW |
|
Anteotech Ltd
ASX:ADO
|
AU |
|
A
|
AXA SA
F:AXA
|
FR |
|
K-Bro Linen Inc
F:74R
|
CA |
|
Adobe Inc
NASDAQ:ADBE
|
US |
|
Five Star Bancorp
F:4F6
|
US |
|
I
|
Imperial Oil Ltd
SWB:IMP
|
CA |
|
I
|
Incyte Corp
F:ICY
|
US |
|
MS&AD Insurance Group Holdings Inc
OTC:MSADY
|
JP |
|
K
|
Kyushu Railway Co
F:KRH
|
JP |
|
C
|
Camden Property Trust
F:CAL
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 2TK.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
2TK
Multiples-Based Value
Base Case
Not Available